lobbying_activities: 1844617

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1844617	1fdfbfcf-bb2e-43dd-abd9-aa5b2811ce32	Q2	COVINGTON & BURLING LLP	11195	FABRE-KRAMER PHARMACEUTICALS, INC	2016	second_quarter	PHA	Policy regarding demonstration of effectiveness for new drug approvals.	HOUSE OF REPRESENTATIVES,SENATE			0	0	2016-07-15T19:14:22.717000-04:00